NCT04466969View on ClinicalTrials.gov

Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study

CompletedOBSERVATIONAL
Enrollment

146

Participants

Timeline

Start Date

July 31, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Hyperkalemia
Trial Locations (5)

457-8511

Research Site, Nagoya

271-0077

Research Site, Matsudoshi

820-8505

Research Site, Iizukashi

306-0433

Research Site, Sashimagun

300-0028

Research Site, Tsuchiurashi

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY